BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chowdhury MM, Williams EJ, Morris JS, Ferguson BJ, McGregor AD, Hedges AR, Stamatakis JD, Pope FM. Severe panniculitis caused by homozygous ZZ alpha1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin). Br J Dermatol. 2002;147:1258-1261. [PMID: 12452881 DOI: 10.1046/j.1365-2133.2002.05095.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 2011;6:14. [PMID: 21486454 DOI: 10.1186/1750-1172-6-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
2 Ortiz PG, Skov BG, Benfeldt E. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options. J Eur Acad Dermatol Venereol. 2005;19:487-490. [PMID: 15987301 DOI: 10.1111/j.1468-3083.2005.01194.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
3 Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol 2016;174:753-62. [DOI: 10.1111/bjd.14309] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
4 Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236. [PMID: 15978931 DOI: 10.1016/s0140-6736(05)66781-5] [Cited by in Crossref: 386] [Cited by in F6Publishing: 113] [Article Influence: 24.1] [Reference Citation Analysis]
5 Lisowska-myjak B. AAT as a diagnostic tool. Clinica Chimica Acta 2005;352:1-13. [DOI: 10.1016/j.cccn.2004.03.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
6 Abboud RT, Nelson TN, Jung B, Mattman A. Alpha1-antitrypsin deficiency: a clinical-genetic overview. Appl Clin Genet 2011;4:55-65. [PMID: 23776367 DOI: 10.2147/TACG.S10604] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
7 Fernández-Torres R, García-Silva J, Robles O, Otero A, Vázquez MA, Fonseca E. Alfa-1-antitrypsin deficiency panniculitis acquired after liver transplant and successfully treated with retransplant. J Am Acad Dermatol 2009;60:715-6. [PMID: 19293031 DOI: 10.1016/j.jaad.2008.10.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004;59:441-5. [PMID: 15115878 DOI: 10.1136/thx.2003.006510] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
9 Velter C, Lipsker D. [Cutaneous panniculitis]. Rev Med Interne 2016;37:743-50. [PMID: 27321570 DOI: 10.1016/j.revmed.2016.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Geraminejad P, DeBloom JR 2nd, Walling HW, Sontheimer RD, VanBeek M. Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol. 2004;51:645-655. [PMID: 15389208 DOI: 10.1016/j.jaad.2003.12.053] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
11 Cathomas M, Schüller A, Candinas D, Inglin R. Severe postoperative wound healing disturbance in a patient with alpha-1-antitrypsin deficiency: the impact of augmentation therapy. Int Wound J 2015;12:601-4. [PMID: 25818083 DOI: 10.1111/iwj.12419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
12 Hatipoğlu U, Stoller JK. α1-Antitrypsin Deficiency. Clin Chest Med 2016;37:487-504. [PMID: 27514595 DOI: 10.1016/j.ccm.2016.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
13 Valverde R, Rosales B, Ortiz-de Frutos FJ, Rodríguez-Peralto JL, Ortiz-Romero PL. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin 2008;26:447-51, vi. [PMID: 18793976 DOI: 10.1016/j.det.2008.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
14 Yesudian PD, Dobson CM, Wilson NJ. alpha1-Antitrypsin deficiency panniculitis (phenotype PiZZ) precipitated postpartum and successfully treated with dapsone. Br J Dermatol. 2004;150:1222-1223. [PMID: 15214923 DOI: 10.1111/j.1365-2133.2004.05991.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Cardoso J. Panniculitis associated with alpha-1 antitrypsin deficiency: from early descriptions to current targeted therapy. Br J Dermatol 2016;174:711-2. [DOI: 10.1111/bjd.14487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
16 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
17 Bergin DA, Hurley K, McElvaney NG, Reeves EP. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz). 2012;60:81-97. [PMID: 22349104 DOI: 10.1007/s00005-012-0162-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 8.9] [Reference Citation Analysis]
18 Al-Niaimi F, Lyon C. Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin. J Am Acad Dermatol. 2011;65:227-229. [PMID: 21679830 DOI: 10.1016/j.jaad.2009.11.587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Johnson EF, Tolkachjov SN, Gibson LE. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases. Int J Dermatol 2018;57:952-8. [DOI: 10.1111/ijd.14012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-259. [PMID: 21960536 DOI: 10.1164/rccm.201108-1428CI] [Cited by in Crossref: 253] [Cited by in F6Publishing: 101] [Article Influence: 25.3] [Reference Citation Analysis]
21 Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, Janciauskiene S. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology. 2009;218:370-375. [PMID: 19218787 DOI: 10.1159/000202982] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
22 Lyon MJ. Metabolic panniculitis: alpha-1 antitrypsin deficiency panniculitis and pancreatic panniculitis. Dermatol Ther. 2010;23:368-374. [PMID: 20666824 DOI: 10.1111/j.1529-8019.2010.01337.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]